Cardinal Health EBITDA 2010-2024 | CAH
Cardinal Health annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Cardinal Health EBITDA for the quarter ending September 30, 2024 was $0.750B, a 435.71% increase year-over-year.
- Cardinal Health EBITDA for the twelve months ending September 30, 2024 was $2.563B, a 100.86% increase year-over-year.
- Cardinal Health 2024 annual EBITDA was $1.953B, a 35.25% increase from 2023.
- Cardinal Health 2023 annual EBITDA was $1.444B, a 1598.82% increase from 2022.
- Cardinal Health 2022 annual EBITDA was $0.085B, a 93.23% decline from 2021.
Cardinal Health Annual EBITDA
(Millions of US $) |
| 2024 |
$1,953 |
| 2023 |
$1,444 |
| 2022 |
$85 |
| 2021 |
$1,255 |
| 2020 |
$-3,185 |
| 2019 |
$3,060 |
| 2018 |
$1,158 |
| 2017 |
$2,837 |
| 2016 |
$3,100 |
| 2015 |
$2,612 |
| 2014 |
$2,344 |
| 2013 |
$1,393 |
| 2012 |
$2,117 |
| 2011 |
$1,827 |
| 2010 |
$1,561 |
| 2009 |
$1,513 |
Cardinal Health Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
$750 |
| 2024-06-30 |
$612 |
| 2024-03-31 |
$544 |
| 2023-12-31 |
$657 |
| 2023-09-30 |
$140 |
| 2023-06-30 |
$338 |
| 2023-03-31 |
$747 |
| 2022-12-31 |
$51 |
| 2022-09-30 |
$308 |
| 2022-06-30 |
$204 |
| 2022-03-31 |
$84 |
| 2021-12-31 |
$-786 |
| 2021-09-30 |
$583 |
| 2021-06-30 |
$342 |
| 2021-03-31 |
$672 |
| 2020-12-31 |
$660 |
| 2020-09-30 |
$-419 |
| 2020-06-30 |
$495 |
| 2020-03-31 |
$786 |
| 2019-12-31 |
$564 |
| 2019-09-30 |
$-5,030 |
| 2019-06-30 |
$549 |
| 2019-03-31 |
$693 |
| 2018-12-31 |
$757 |
| 2018-09-30 |
$1,061 |
| 2018-06-30 |
$-828 |
| 2018-03-31 |
$805 |
| 2017-12-31 |
$690 |
| 2017-09-30 |
$491 |
| 2017-06-30 |
$630 |
| 2017-03-31 |
$791 |
| 2016-12-31 |
$708 |
| 2016-09-30 |
$708 |
| 2016-06-30 |
$796 |
| 2016-03-31 |
$815 |
| 2015-12-31 |
$732 |
| 2015-09-30 |
$757 |
| 2015-06-30 |
$673 |
| 2015-03-31 |
$707 |
| 2014-12-31 |
$658 |
| 2014-09-30 |
$574 |
| 2014-06-30 |
$502 |
| 2014-03-31 |
$618 |
| 2013-12-31 |
$636 |
| 2013-09-30 |
$588 |
| 2013-06-30 |
$-320 |
| 2013-03-31 |
$574 |
| 2012-12-31 |
$594 |
| 2012-09-30 |
$545 |
| 2012-06-30 |
$490 |
| 2012-03-31 |
$610 |
| 2011-12-31 |
$527 |
| 2011-09-30 |
$490 |
| 2011-06-30 |
$433 |
| 2011-03-31 |
$545 |
| 2010-12-31 |
$417 |
| 2010-09-30 |
$432 |
| 2010-06-30 |
$394 |
| 2010-03-31 |
$435 |
| 2009-12-31 |
$426 |
| 2009-09-30 |
$306 |
| 2009-06-30 |
$364 |
| 2009-03-31 |
$434 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$28.315B |
$226.827B |
|
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
|
